Pierre Giglio to Receptor, Fibroblast Growth Factor, Type 3
This is a "connection" page, showing publications Pierre Giglio has written about Receptor, Fibroblast Growth Factor, Type 3.
Connection Strength
0.052
-
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clin Cancer Res. 2022 06 01; 28(11):2270-2277.
Score: 0.052